Health Care/Hospital APAC News & Press Release Distribution

Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China

* Collaboration to accelerate the development and access of oncology medicines for cancer patients inChina * Clinical trial programs combining two of Sanofi's prioritized oncology assets with sintilimab, the leading checkpoint inhibitor inChina, to address some of the most prevalent solid tum...

2022-08-04 23:30 3784

MGI Announces Commercial Availability of HotMPS Sequencing Chemistry*and Instrument**in the United Kingdom

SHENZHEN, China, July 28, 2022 /PRNewswire/ -- MGI Tech (MGI) announced that its innovative HotMPS sequencing chemistry* and instrument** are commercially available in theUnited Kingdom, from 23rd June 2022. Further details will be communicated during the 17th Annual Meeting of the International ...

2022-08-04 22:50 2435

Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector

* Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology clinical trials market * Genesis Capital is partnering with existing management to expand ...

2022-08-04 22:01 3094

TCEB and Phuket Welcome Enquiry Mission Members from World Expo's Governing Body to Assess Phuket's Candidacy for Expo 2028

BANGKOK, Aug. 4, 2022 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in partnership withPhuket City and Thailand's Ministry of Public Health, welcomed nine Enquiry Mission Members from Bureau International des Expositions (BIE), the governing body of World Expos, as guests of t...

2022-08-04 19:08 2015

TCEB and Phuket Welcome Enquiry Mission Members from World Expo's Governing Body to Assess Phuket's Candidacy for Expo 2028

Fullerton Health Completes Merger Led By RRJ Capital; Stronger Balance Sheet and New Corporate Structure Will Propel Post-Pandemic Growth Opportunities

SINGAPORE, Aug. 4, 2022 /PRNewswire/ -- Fullerton Health Corporation Limited ("Fullerton Health" or the "Company") announced today that it has completed a merger led by RRJ Capital ("RRJ") involving an equity injection by the private equity firm and a senior loan totallingS$390 million. The merge...

2022-08-04 13:11 5626

Fullerton Health Completes Merger Led By RRJ Capital; Stronger Balance Sheet and New Corporate Structure Will Propel Post-Pandemic Growth Opportunities

Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA

HANGZHOU, China and SHAOXING, China, Aug. 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for COVID-19, has been accep...

2022-08-04 08:10 2426

Ping An Ranks 25th in the Fortune Global 500 List, 1st among mixed-ownership Chinese enterprises

HONG KONG and SHANGHAI, Aug. 3, 2022 /PRNewswire/ -- With sustained performance and growth, Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An " or the "Group", HKEX: 2318; SSE: 601318) ranked 25th on the 2022 Fortune Global 500 list with its revenue recordedUSD199.6 billion in 20...

2022-08-03 21:44 4003

HAVAS HEALTH & YOU PARTNERS WITH REPUBLICA HAVAS TO CREATE REPUBLICA HAVAS HEALTH

New Offering Architects Health and Wellness Programs that Lead Cultural Understanding, Foster Health Equity For Multicultural Populations and Bring Deep Fluency and Multicultural Capabilities to World's Largest Health Network NEW YORK, Aug. 3, 2022 /PRNewswire/ -- Havas Health & You, the world's...

2022-08-03 21:00 1939

HIGHLIGHTS FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference® (AAIC®) 2022 covered the breadth of Alzheimer's and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and caregiving ...

2022-08-03 20:00 1831

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ --Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer's Association International Conference®(AAIC®) 2022 in S...

2022-08-03 20:00 2104

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

TikoMed's ILB® activates the body's natural repair signals to restore glutamate homeostasis, amino acid metabolism and neurocognitive functions in a rat model of severe traumatic brain injury

VIKEN, Sweden, Aug. 3, 2022 /PRNewswire/ -- A new study with TikoMed's lead drug candidate, ILB®, addressing underlying causes of neurodegeneration in acute and chronic diseases, was published in the International Journal of Molecular Sciences today. The data from the rodent model studying severe...

2022-08-03 17:23 1245

Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients

-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A, which is the same active metabolite of molnupiravir -- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a n...

2022-08-03 16:50 2109

Technology Solutions to Boost Employee Experience and Improve Patient Outcomes

Workforce management solutions from DXC and SAP support healthcare providers in managing their teams while focusing on employees' well-being and ability to deliver quality care SAN ANTONIO, Aug. 3, 2022 /PRNewswire/ -- Healthcare providers may find that supporting their care team and managing th...

2022-08-03 15:12 1750

Yidu Tech Releases FY2022 ESG Report, Using Socially Beneficial Technology to Drive the Sustainable Development of "Green Healthcare"

HONG KONG, Aug. 3, 2022 /PRNewswire/ -- The digital economy powered by innovative technologies such as artificial intelligence ("AI") and big data has become one of the most powerful drivers of economic growth since the COVID-19 outbreak, in keeping withChina's core strategy of "digitalization, ...

2022-08-03 15:09 1834

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

HAMBURG, Germany, Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory ofKenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. The NPHL operates under Kenya's Ministry of Health and plays...

2022-08-03 14:00 1767

Ogawa World Berhad Won the Asia Pacific Enterprise Awards 2022 Malaysia under Inspirational Brand Category

KUALA LUMPUR, Malaysia, Aug. 3, 2022 /PRNewswire/ -- Enterprise Asia, the organizer of the 13th Asia Pacific Enterprise Awards (APEA) 2022 Malaysia, is pleased to recognize 47 exceptional business leaders and enterprises that have played a vital role in shapingMalaysia's entrepreneurial landscape...

2022-08-03 13:14 2856

Lim Chin Hau and Medicap Sdn Bhd Awarded at the Asia Pacific Enterprise Awards 2022 Malaysia

KUALA LUMPUR, Malaysia, Aug. 3, 2022 /PRNewswire/ -- Enterprise Asia, the organizer of the 13th Asia Pacific Enterprise Awards (APEA) 2022 Malaysia, is pleased to recognize 47 exceptional business leaders and enterprises that have played a vital role in shapingMalaysia's entrepreneurial landscape...

2022-08-03 13:12 2271

Lim Chin Hau and Medicap Sdn Bhd Awarded at the Asia Pacific Enterprise Awards 2022 Malaysia

Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines

TAIZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:02179.HK) is pleased to announce that, the Company has recently received the clinical trial approval for its recombinant protein COVID-19 vaccine,...

2022-08-03 13:09 2781

Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

* ATG-101 is a novel PD-L1/4-1BB bispecific antibody. It is Antengene's first in-house developed molecule with global rights. * ATG-101 demonstrates potent in vivo efficacy in anti-PD-1/PD-L1 resistant mouse tumor models. SHANGHAI and HONG KONG, Aug. 3, 2022 /PRNewswire/ -- Antengene Corpora...

2022-08-03 08:30 1863

Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China

- Robust HbA1c reduction of 2.4% was observed with 1.2 mg XW003 dose - Up to 88% of participants achieved HbA1c ≤ 7% and up to 72% achieved HbA1c ≤6.5% at the end of the 20-week treatment - XW003 was safe and well tolerated with gastrointestinal side effects as the most commonly reported adve...

2022-08-03 08:00 1801